Core Laboratories N.V. Financials

Market Capitalization €973.8 Million as of Dec. 1, 2022

Valuations Metrics as of Jan. 25, 2025

Trailing PE	65.63
Forward PE	23.86
Price to Sales TTM	€2.00
Price to Book MRQ	€5.45
Enterprise to Revenue	2.46
Enterprise to EBITDA	20.65

Financial Reports as of Sep. 30, 2022

Financials

Fiscal Year Ends	2021-12-31
Most Recent Quarter	2022-09-30
Profit Margin	3.16%
Operating Margin	8.35%
Return on Assets TTM	4.40%
Return on Equity TTM	9.15%

Income Statement

Revenue TTM	€448,879,165
Revenue per Share TTM	€10.53
Quarterly Revenue Growth	6.80%
Gross Profit TTM	€94,285,229
EBITDA	€54,697,000
Net Income to Common TTM	€14,176,498
Diluted EPS TTM	€0.32
Quarterly Earnings Growth YoY	760.90%

Balance Sheet

Total Cash MRQ	€12,649,231
Total Cash per Share MRQ	€0.30
Total Debt MRQ	€
Total Debt to Equity MRQ	128.82
Current Ratio MRQ	2.24
Book Value per Share MRQ	€3.85

Cash Flow

Operating Cash Flow TTM	€17,408,813
Levered Free Cash Flow TTM	€13,515,343

CLB Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	46,371,300
Float Shares	46,125,077
Avg 10 Volume	1,624
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	0.52%
% Held by Institutions	108.06%

Stock Price Summary

Beta	2.64
Fifty Two Week Low	€13.60
Fifty Two Week High	€32.00
Fifty Two Week Change	0.09%
Day 50 MA	€18.79
Day 200 MA	€21.25

Dividends and Splits

Forward Annual Dividend Rate	€0.04
Forward Annual Dividend Yield	0.19%
Trailing Annual Dividend Rate	€0.04
Trailing Annual Dividend Yield	0.19%
Payout Ratio	11.76%
Dividend Date
Ex Dividend Date	2022-11-04
Last Split Factor
Last Split Date